GABAAreceptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Gamma‐aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system.GABA type A receptors (GABA A R s) are severely affected in Alzheimer's disease (AD). However, the distribution and subunit composition of GABA A R s in the AD brain are not well understood. This is the first comprehensive study to show brain region‐ and cell layer‐specific alterations in the expression of the GABA A R subunits α1‐3, α5, β1‐3 and γ2 in the human AD hippocampus, entorhinal cortex and superior temporal gyrus. In late‐stage AD tissue samples using immunohistochemistry we found significant alteration of all investigated GABA A R s subunits except for α3 and β1 that were well preserved. The most prominent changes include an increase in GABA A R α1 expression associated with AD in all layers of the CA 3 region, in the stratum (str.) granulare and hilus of the dentate gyrus. We found a significant increase in GABA A R α2 expression in the str. oriens of the CA 1‐3, str. radiatum of the CA 2,3 and decrease in the str. pyramidale of the CA 1 region in AD cases. In AD there was a significant increase in GABA A R α5 subunit expression in str. pyramidale, str. oriens of the CA 1 region and decrease in the superior temporal gyrus. We also found a significant decrease in the GABA A R β3 subunit immunoreactivity in the str. oriens of the CA 2, str. granulare and str. moleculare of the dentate gyrus. In conclusion, these findings indicate that the expression of the GABA A R subunits shows brain region‐ and layer‐specific alterations in AD, and these changes could significantly influence and alter GABA A R function in the disease. image Cover Image for this issue: doi:10.1111/jnc.14179.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 1×
“Tonic inhibition is mediated by peri- or extrasynaptic high affinity GABAARs mostly assembled by a5, a4, either b and a d subunit; low concentrations of ambient GABA can persistently activate these subtypes of GABAAR to generate a tonic conductance (Farrant and Nusser 2005; Glykys and Mody 2006).”
BackgroundProfound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 5×
“In regions like the CA1 (West et al. 1994), entorhinal cortex (Gomez-Isla et al. 1996) and STG (GomezIsla et al. 1997) with the most severe cell loss and increased c2 subunit labelling it is proposed that the death of the pyramidal neurons precedes the neurofibrillary pathology © 2018 International…”
BackgroundInfluentialPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“…et al. 1994) and entorhinal cortex (Gomez-Isla et al. 1996), exhibit the most severe decrease in a1 subunit expression but interestingly no alterations are observed in the STG with a less severe but still significant cell loss (West et al. 1994; Gomez-Isla et al. 1996, 1997; Fuhrer et al. 2017).”
BackgroundDifferences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · cited 3×
“…studies using pharmacological agents and genetic manipulations have confirmed that the a5 subunit plays a role in hippocampus-dependent learning (Collinson et al. 2002; Crestani et al. 2002; Chambers et al. 2004; Yee et al. 2004; Dawson et al. 2006; Gerdjikov et al. 2008), in generating gamma…”
BackgroundJurd, R., Arrasa, M., Lambert, S., Drexler, B., Siegwart, R., Crestani, F., Zaugg, M., Vogt, K. E., Ledermann, B., Antkowiak, B., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0611fje · Cited by 558
Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550 · cited 1×
“The c2 knockouts die shortly after birth but the c2 +/ mice are models for anxiety characterized by harm avoidance behaviour and explicit memory bias for threat cues, leading to heightened sensitivity to negative associations (Crestani et al. 1999).”
BackgroundTrace fear conditioning involves hippocampal α 5 GABA A receptors
Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528
Rudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
Structure and subunit composition of GABAA receptors
Sieghart, W., Fuchs, K., Tretter, V, Ebert, V, Jechlinger, M., Höger, H., & Adamiker, D. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00045-5 · Cited by 306
Wu, Z., Guo, Z., Gearing, M., & Chen, G. (2014) · Nature Communications · doi:10.1038/ncomms5159 · Cited by 306
Seizures and Epilepsy in Alzheimer's Disease
Friedman, D., Honig, L. S., & Scarmeas, N. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00251.x · Cited by 229
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208 · cited 3×
“Importantly, these studies and our findings suggest that further research is needed to clarify how altered GABAAR subunit expression, composition and pharmacology in AD patients might change GABAergic drug responses (Govindpani et al. 2017).”
BackgroundSelf-citationEarnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H., & Lüscher, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3609-06.2007 · Cited by 203
Memory Deficits Induced by Inflammation Are Regulated by α5-Subunit-Containing GABAA Receptors
Wang, D.-S., Zurek, A. A., Lecker, I., Yu, J., Abramian, A. M., Avramescu, S., Davies, P. A., Moss, S. J., Lu, W.-Y., & Orser, B. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.022 · Cited by 182
EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Vellas, B., Sol, O., J. Snyder, P., Ousset, P.-J., Haddad, R., Maurin, M., Lemarie, J.-C., Desire, L., & P. Pando, M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256053 · Cited by 133 · cited 2×
“Indeed, many GABAergic drugs have been studied in relation to AD, some of them targeting the impaired excitatory/inhibitory balance while others ameliorating the neurotoxic effect of beta-amyloid (Atack 2010; Drott et al. 2010; Vellas et al. 2011; Solas et al. 2015; Li et al. 2016; Govindpani et al. 2017).”
BackgroundGerdjikov, T. V., Rudolph, U., Keist, R., Möhler, H., Feldon, J., & Yee, B. K. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.06.003 · Cited by 43
Cited by
Wang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.002 · Cited by 185
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
Carello-Collar, G., Bellaver, B., Ferreira, P. C. L., Ferrari-Souza, J. P., Ramos, V. G., Therriault, J., Tissot, C., De Bastiani, M. A., Soares, C., Pascoal, T. A., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02140-w · Cited by 98
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
Ratner, M. H., Kumaresan, V., & Farb, D. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00169 · Cited by 96
Chakroborty, S., Hill, E. S., Christian, D. T., Helfrich, R., Riley, S., Schneider, C., Kapecki, N., Mustaly-Kalimi, S., Seiler, F. A., Peterson, D. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0307-7 · Cited by 71
Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69
“On the other hand, GABA A receptor subunit expression in the hippocampus, subiculum, entorhinal cortex, and superior temporal gyrus regions revealed that the expressions of GABA A receptor subunits had region-and layer-specific effects from [82] AD [83].”
Metadata
- Authors
- Kwakowsky, A., Calvo‐Flores Guzmán, B., Pandya, M., Turner, C., Waldvogel, H. J., & Faull, R. L.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2018-05-30
- Volume
- 145
- Issue
- 5
- Pages
- 374-392
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2792350373
- Cited by
- 95
- References
- 22
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.